Innovotech Inc.

Innovotech Inc.

June 10, 2008 11:55 ET

Innovotech Initiates Field Trials for Novel Seed Treatment, Agress™

EDMONTON, ALBERTA--(Marketwire - June 10, 2008) - Innovotech Inc. (TSX VENTURE:IOT), in partnership with agricultural stations in Alberta, Saskatchewan, and Manitoba, is pleased to announce the initiation of summer field trials with its novel seed treatment, Agress™. Innovotech is testing the efficacy of Agress™ against multiple diseases on beans, peas, and soybeans to advance its marketing plan and recent registration application with Health Canada and the US Environmental Protection Agency.

"This is the next step to verify the efficacy of Agress™ in real world conditions that a farmer might face, using multiple locations across Canada to simulate variability of climate and soil conditions. It is also the next step in expanding the disease and crop scope for Agress™," says Damian Sowa, Product Manager, Innovotech. "Agress™ will break new ground in crop protection, coupling environmental friendliness with broad spectrum effectiveness at low rates of application."

Innovotech anticipates regulatory approval for Agress™ in Canada and the United States mid- to late-2009, permitting sales launch for the 2010 season. Research is currently underway to expand the claims of Agress™ to the major crops in North America and additional disease classes.

About Innovotech Inc:

Innovotech is a product development company focusing on the development of solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are protected communities of microorganisms which are very common and very difficult to treat due to their inherent resistance. They have been implicated in a host of devastating infections in agriculture, human health and industry. No diagnostics or antibiotics are currently approved for use in infections involving biofilms.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information